Showing results (121-130 of 142) with videos related to
Sort By:
Pageof 15
Anti-Cancer Drugs|April 1, 1995
Schedule-dependent enhancement of antitumor activity of ethyldeshydroxy-sparsomycin in combination with classical antineoplastic agentsH P Hofs, D J Wagener, V de Valk-Bakker, et al.Gut|August 1, 1990
Pancreatic carcinoma with polyarthritis, fat necrosis, and high serum lipase and trypsin activityR J van Klaveren, P H de Mulder, A M Boerbooms, et al.Investigational New Drugs|January 1, 1995
Preclinical antitumor activity of ethyldeshydroxysparsomycin in combination with cisplatinH P Hofs, D J Wagener, V De Valk-Bakker, et al.European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG studyD J Wagener, W J Hoogenraad, P Rougier, et al.Journal of the National Cancer Institute|April 1, 1987
In vitro modulation of cisplatin cytotoxicity by sparsomycin inhibition of protein synthesisZ Zylicz, D J Wagener, H van Rennes, et al.Surgical Endoscopy|November 1, 1997
Laparoscopic fundoplication to enhance pulmonary function in children with severe reactive airway disease and gastroesophageal reflux diseaseS S Rothenberg, D Bratton, G Larsen, et al.Cancer Letters|July 1, 1986
In vivo potentiation of cis-diamminedichloroplatinum (II) antitumor activity by pretreatment with sparsomycinZ Zylicz, D J Wagener, H van Rennes, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2006
Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter studyD A Richards, K A Boehm, D M Waterhouse, et al.Cancer Chemotherapy and Pharmacology|April 2, 1998
A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I studyO van Tellingen, C J Punt, A Awada, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1992
Phase II trials of fosquidone (GR63178A) in carcinoma of the breast, head and neck, ovary and melanomaS B Kaye, J Wanders, M Clavel, et al.Pageof 15